These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16940437)

  • 21. Inflammation induces tau pathology in inclusion body myositis model via glycogen synthase kinase-3beta.
    Kitazawa M; Trinh DN; LaFerla FM
    Ann Neurol; 2008 Jul; 64(1):15-24. PubMed ID: 18318434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endoplasmic reticulum stress and unfolded protein response in inclusion body myositis muscle.
    Vattemi G; Engel WK; McFerrin J; Askanas V
    Am J Pathol; 2004 Jan; 164(1):1-7. PubMed ID: 14695312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amyloid-beta deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathy.
    Fukuchi K; Pham D; Hart M; Li L; Lindsey JR
    Am J Pathol; 1998 Dec; 153(6):1687-93. PubMed ID: 9846958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-amyloid peptide expression is sufficient for myotube death: implications for human inclusion body myopathy.
    Querfurth HW; Suhara T; Rosen KM; McPhie DL; Fujio Y; Tejada G; Neve RL; Adelman LS; Walsh K
    Mol Cell Neurosci; 2001 May; 17(5):793-810. PubMed ID: 11358479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular pathology and pathogenesis of inclusion-body myositis.
    Askanas V; Engel WK
    Microsc Res Tech; 2005 Jul; 67(3-4):114-20. PubMed ID: 16104000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenic considerations in sporadic inclusion-body myositis, a degenerative muscle disease associated with aging and abnormalities of myoproteostasis.
    Askanas V; Engel WK; Nogalska A
    J Neuropathol Exp Neurol; 2012 Aug; 71(8):680-93. PubMed ID: 22805774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does overexpression of betaAPP in aging muscle have a pathogenic role and a relevance to Alzheimer's disease? Clues from inclusion body myositis, cultured human muscle, and transgenic mice.
    Askanas V; Engel WK
    Am J Pathol; 1998 Dec; 153(6):1673-7. PubMed ID: 9846956
    [No Abstract]   [Full Text] [Related]  

  • 28. Sporadic inclusion body myositis: morphology, regeneration, and cytoskeletal structure of muscle fibres.
    Arnardottir S; Borg K; Ansved T
    J Neurol Neurosurg Psychiatry; 2004 Jun; 75(6):917-20. PubMed ID: 15146016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NOGO is increased and binds to BACE1 in sporadic inclusion-body myositis and in A beta PP-overexpressing cultured human muscle fibers.
    Wojcik S; Engel WK; Yan R; McFerrin J; Askanas V
    Acta Neuropathol; 2007 Nov; 114(5):517-26. PubMed ID: 17764014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AbetaPP-overexpression and proteasome inhibition increase alphaB-crystallin in cultured human muscle: relevance to inclusion-body myositis.
    Wojcik S; Engel WK; McFerrin J; Paciello O; Askanas V
    Neuromuscul Disord; 2006 Dec; 16(12):839-44. PubMed ID: 17056255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fast-twitch sarcomeric and glycolytic enzyme protein loss in inclusion body myositis.
    Parker KC; Kong SW; Walsh RJ; ; Salajegheh M; Moghadaszadeh B; Amato AA; Nazareno R; Lin YY; Krastins B; Sarracino DA; Beggs AH; Pinkus JL; Greenberg SA
    Muscle Nerve; 2009 Jun; 39(6):739-53. PubMed ID: 19291799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transgenic mice expressing the human C99 terminal fragment of betaAPP: effects on cytochrome oxidase activity in skeletal muscle and brain.
    Strazielle C; Dumont M; Fukuchi K; Lalonde R
    J Chem Neuroanat; 2004 Jul; 27(4):237-46. PubMed ID: 15261330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice.
    Dewachter I; van Dorpe J; Spittaels K; Tesseur I; Van Den Haute C; Moechars D; Van Leuven F
    Exp Gerontol; 2000 Sep; 35(6-7):831-41. PubMed ID: 11053674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-amyloid is a substrate of autophagy in sporadic inclusion body myositis.
    Lünemann JD; Schmidt J; Schmid D; Barthel K; Wrede A; Dalakas MC; Münz C
    Ann Neurol; 2007 May; 61(5):476-83. PubMed ID: 17469125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies.
    Choi YC; Dalakas MC
    Neurology; 2000 Jan; 54(1):65-71. PubMed ID: 10636127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sporadic inclusion-body myositis and its similarities to Alzheimer disease brain. Recent approaches to diagnosis and pathogenesis, and relation to aging.
    Askanas V; Engel WK
    Scand J Rheumatol; 1998; 27(6):389-405. PubMed ID: 9855208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myostatin is increased and complexes with amyloid-beta within sporadic inclusion-body myositis muscle fibers.
    Wójcik S; Engel WK; McFerrin J; Askanas V
    Acta Neuropathol; 2005 Aug; 110(2):173-7. PubMed ID: 15983828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased BACE1 mRNA and noncoding BACE1-antisense transcript in sporadic inclusion-body myositis muscle fibers--possibly caused by endoplasmic reticulum stress.
    Nogalska A; Engel WK; Askanas V
    Neurosci Lett; 2010 May; 474(3):140-143. PubMed ID: 20236612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HMGB1 and RAGE in skeletal muscle inflammation: Implications for protein accumulation in inclusion body myositis.
    Muth IE; Zschüntzsch J; Kleinschnitz K; Wrede A; Gerhardt E; Balcarek P; Schreiber-Katz O; Zierz S; Dalakas MC; Voll RE; Schmidt J
    Exp Neurol; 2015 Sep; 271():189-97. PubMed ID: 26048613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p62/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis.
    Nogalska A; Terracciano C; D'Agostino C; King Engel W; Askanas V
    Acta Neuropathol; 2009 Sep; 118(3):407-13. PubMed ID: 19557423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.